Analyzing the Policy Framework of Human-Relevant, Transformative Scientific Innovations
On June 23, 2022, the Center for Contemporary Sciences (CCS) hosted its inaugural Discovery Forum. The event was an opportunity to analyze the policy framework underlying the most transformative scientific innovations of the decade. Emphasis was placed on new inventions enabled by advances in regenerative medicine, biomedical engineering, machine learning, and nanotechnology. This included applications […]
‘The End of Medicine’ Action Plan
Moved by ‘The End of Medicine’ Film Discussion to act? Here are some steps you can take that will help prevent the next pandemic, reduce the human health impact from animal agriculture, and support animal protection. View File
House Committee Passes Key Legislations Clearing the Path for Congressional Action
Significant legislative progress related to healthcare innovation and human-relevant testing has been underway on Capitol Hill. On May 11, 2022, The House Energy and Commerce Health Subcommittee passed H.R. 7667, the Food and Drug Amendments of 2022. This step paved the way for comments and markup at the full committee meeting, which occurred on May 18, […]
Animals in Laboratories Speak
Every year, more than 100 million animals are used in experimentation in the U.S. The Animal Welfare Act (AWA) is the only U.S. federal statute that regulates the treatment of animals used in experiments. However, it excludes >95% of animals used. Additionally, even for the species which are covered, the AWA provides no limits on […]
CCS Investor Summit 2022 Report
On March 24, 2022, CCS hosted its first ever Investor Summit in partnership with Beyond Animal. The Summit was open to the public and brought together an international group of innovators, investors, researchers, start-ups, and venture philanthropists. The packed, three-hour-Summit was an opportunity to provide needed exposure to business entities in the space, promote the […]
CCS’s co-written opinion piece published in The Hill prompts a thoughtful thank you letter from Congresswoman Anna Eshoo
The creation of a $6.5 billion Advanced Research Projects Agency for Health, also known as ARPA-H, is a new initiative proposed by President Biden in his full budget request to Congress for Fiscal Year 2022. ARPA-H is to be modeled after the similarly named Defense Advanced Research Projects Agency (DARPA). The goal of ARPA-H is […]
CCS to host first Investor Summit
On March 24, 2022, the Center for Contemporary Sciences (CCS) is pleased to host its first Investor Summit 2022. This one-of-a-kind business development event, held in partnership with Beyond Animal, is open to the public and brings together an international group of innovators, investors, researchers, start-ups, and venture philanthropists. The three-hour-event is designed to promote […]
2021 Year in Review
CCS Public Disclosure 990 2021
It’s Time to Modernize Medical Science
Stacked away in my basement is an old 8-track cassette player that I used as a kid in the late 1970’s. I keep it to remind me how far science can advance if there is the will to do so. The 8-tracks first hit the market in the mid-1960’s and were considered state of the […]
CCS Cheers Bipartisan Introduction of the FDA Modernization Act of 2021 to Innovate Drug Development and Replace Animal Testing Requirements
The Center for Contemporary Sciences (CCS) Cheers Bipartisan Introduction of the FDA Modernization Act of 2021 to Innovate Drug Development and Replace Animal Testing Requirements Washington, D.C. – Today, U.S. Senators Cory Booker, D-N.J., Rand Paul, R-Ky., Ben Ray Lujan, D-N.M., Mike Braun, R-Ind., and John Kennedy, R-La., introduced the FDA Modernization Act of 2021 […]
A Student’s Perspective on Human-Relevant Testing Models
Debating animal research was never a particularly central topic throughout my short life so far as a university student. There are the occasional animal activist campaigns about how companies need to stop using them to test cosmetics or drugs, and how ‘Mouse Lives Matter Too!’ I remember the flyers being passed around in the lecture theatres, the posters dotted around […]
CCS is Named a 2021 Classy Awards Finalist
We are excited to announce that CCS has been named a Top 50 Finalist for the 2021 Classy Awards! Classy, which provides information, support and technology for nonprofits, launched the Classy Awards in 2009 to recognize the achievements of nonprofits and social enterprises operating in our communities and around the world. It’s goal is to shine a spotlight […]
The Future of Parkinson’s Disease Research
Check out CCS’s latest scientific publication on Parkinson’s Disease research. In coordination with the Center for Alternatives to Animal Testing (CAAT), CCS held a workshop May 2021 to develop a scheme that outlines the basic research and testing approaches necessary to make PD research a success—elucidating pathological mechanisms, identifying knowledge gaps, discovering druggable targets, and developing […]
CCS Announces Partnership with GlassWall Syndicate
CCS is announcing a new partnership with GlassWall Syndicate to provide funding to companies developing alternatives to animal testing. To apply to this funding opportunity, organizations must be working on a technology or product that can replace the use of animals in experimentation.